| Literature DB >> 31827773 |
Lisa Loughney1, Ronan Cahill2,3, Kiaran O'Malley4, Noel McCaffrey1, Brona Furlong1.
Abstract
BACKGROUND: Pre-operative exercise training improves HR components of fitness and HRQoL following hospital-based programmes.Entities:
Keywords: Colorectal cancer; Community; Pre-operative Exercise training; Prostate cancer; Surgery; Surgical-oncology
Year: 2019 PMID: 31827773 PMCID: PMC6886214 DOI: 10.1186/s13741-019-0126-y
Source DB: PubMed Journal: Perioper Med (Lond) ISSN: 2047-0525
Fig. 1Study flow algorithm illustrating patient pathway
Exercise training prescription described using the FITT principle (frequency, intensity, time, type) and progression
| Frequency | 3–5 sessions per week depending on the time interval before surgery (i.e. if patients had a 2-week interval, they were advised to undertake 5 sessions per week or > 2 weeks, they were advised to undertake ≥ 3 sessions per week). |
| Intensity | (1) Interval (moderate to high intensity) exercise training: moderate and high intensities, derived based on RPE scale (13: somewhat hard and 15: hard) using the same concept as (West et al. (2) High-intensity exercise training: derived based on RPE scale (16: hard to very hard) using the same concept as (Boereboom et al. (3) Resistance training included performing 3 sets × 12 repetitions. The load was selected based on individual ability (i.e. kg of weight using 12 RM with a minimum 30 s recovery period between each set) |
| Time | Total: ranged between 40 to 60 min “(1) The first interval (moderate to high intensity) exercise session was 30 min: 5-min warm-up followed by 4 repeated bouts of moderate intensity (3 min) to high-intensity (2 min) intervals and 5 min cool down. The second sessions onwards was 40 min: 5-min warm-up followed by 6 repeated bouts of moderate intensity (3 min) to high intensity (2 min) intervals and 5 min cool down. (2) The high-intensity exercise training was 17.5 min: 2 min warm-up followed by 5 repeated bouts of high intensity (1 min) and recovery (90 s) intervals and a 3 min cool down.” (3) Resistance training involved completing 3 sets × 12 repetitions (approx. 20 min). |
| Type | Aerobic training, upright cycle ergometer, recumbent cycle ergometer, treadmill, elliptical ergometer and rowing ergometer, depending on patient preference. Resistance training involved a circuit of strength 8–10 stations alternating upper and lower body exercises using the following machines: shoulder press, lateral pulldown, tricep press, squat, chest press, leg extension, hamstring curl, and back row. |
| Progression | Exercise intensity (interval/high) was progressed every 5 sessions (i.e. the intensity was increased by 1 level). Resistance training progressed following completion of 3 consecutive sessions comfortably (i.e. weight was increased by 1 kg). |
The aerobic high-intensity training was only prescribed to certain individuals who could tolerate the interval training very well. The aerobic exercise training included interval and high-intensity training, which were alternated between every second sessions
RPE rate of perceived exertion, CPET cardiopulmonary exercise test, RM repetition maximum
Participant characteristics
| Prostate (n=15) | Colorectal (n=17) | P-value | Overall (n=32) | |
|---|---|---|---|---|
| Gender M:F (ratio) | 15:0 | 13:4 | 0.168 | 28:4 |
| Age (years) | 64.2 (6.7) | 60.5 (12.1) | 0.047* | 60.5 (10.9) |
| Height (cm) | 174 (5.7) | 172 (8.5) | 0.993 | 174.3 (5.9) |
| Weight (kg) | 89.6 (12.5) | 87.7 (21.6) | 0.883 | 89.6 (16.4) |
| BMI (kg/m2) | 29.7 (3.5) | 29.5 (6.9) | 0.898 | 29.7 (4.8) |
| Current smoker┼ | 0 (0) | 1 (6) | 0.343 | 1 (3) |
| No. of participants with co-morbidity┼ | 8 (53) | 7 (6) | 0.431 | 15 (47) |
| No. of participants taking medication┼ | 7 (47) | 6 (35) | 0.538 | 13 (41) |
Data are reported as mean (SD).*P < 0.05 taken as statistically significant. ┼Frequencies with percentages in parentheses
Health-related components of fitness at baseline and post-exercise intervention for prostate and colorectal cancer participants
| Prostate (n=14) | Colorectal (n=10) | |||||||
|---|---|---|---|---|---|---|---|---|
| Outcome measure | Baseline | Post-intervention | Mean Difference (95% CI) | P value | Baseline | Post-intervention | Mean Difference (95% CI) | P value |
| Sit-to-stand (s) | 16.4 (6.6) | 14.2 (6.1) | 2.2 (0.6, 4.3) | 0.045* | 16.6 (5.9) | 13.8 (4.9) | 2.8 (1.5, 4.2) | 0.001* |
| Handgrip (kg) | 32.6 (9.6) | 33.6 (8.6) | -1.0 (-2.8, 0.8) | 0.259 | 33.7 (8.9) | 35.3 (8.5) | -0.5 (-2.9, 1.9) | 0.637 |
| 6MTT (m) | 684 (144) | 722 (136) | -38 (-108, 32) | 0.262 | 768 (230) | 779 (220) | -11 (-51, 28) | 0.528 |
Data are presented as mean (SD). *P < 0.05 taken as statistically significant
Health-related components of fitness at baseline and post-exercise intervention for both surgical-oncology groups combined
| Outcome measure | Baseline ( | Post-intervention ( | Mean difference (95% CI) | |
|---|---|---|---|---|
| Sit-to-stand (s) | 16.5 (6.2) | 14.0 (5.5) | 2.5 (1.2, 3.7) | 0.001* |
| Handgrip (kg) | 33.2 (9.1) | 34.3 (8.4) | − 0.8 (− 2.1, 0.5) | 0.232 |
| 6MTT (m) | 719 (185) | 746 (173) | − 27 (− 68, 15) | 0.193 |
Data are presented as mean (SD). *P < 0.05 taken as statistically significant
Health-related quality of life at baseline and post-exercise intervention for prostate and colorectal cancer participants
| HRQoL Questionnaires | Prostate | Colorectal | ||||||
|---|---|---|---|---|---|---|---|---|
| EORTC QLQ-C30 questionnaire┼ | Baseline | Post-intervention | Mean Difference (95% CI) | P value | Baseline | Post-intervention | Mean Difference (95% CI) | P value |
| 73.1 (19.0) | 80.1 (15.4) | -7.1 (-20.5, 6.4) | 0.276 | 69.2 (15.2) | 83.3 (13.6) | -15.7 (-28.7, -2.8) | 0.025* | |
| 93.8 (8.8) | 92.8 (6.9) | 1.0 (-2.2, 4.2) | 0.505 | 94 (10.2) | 94.7 (11.7) | -0.7 (-4.7, 3.3) | 0.677 | |
| 93.1 (19.4) | 89.7 (19.9) | -1.4 (-16, 13.2) | 0.838 | 90.7 (14.7) | 92.6 (12.1) | -2.1 (-15.9, 11.7) | 0.729 | |
| 73.7 (19.2) | 84.6 (13.1) | -10.9 (-21.7, -0.1) | 0.048* | 75.2 (28.6) | 85 (10.2) | -11.8 (-34, 10.2) | 0.293 | |
| 89.7 (14.5) | 91.0 (11.0) | -1.3 (-10, 7.4) | 0.754 | 93.3 (11.7) | 100 (0) | -7.4 (-16.7, 1.9) | 0.104 | |
| 87.2 (26.5) | 92.3 (12.9) | -5.1 (-18.4, 8.1) | 0.416 | 86.7 (18.9) | 90 (11.7) | -3.7 (-19.1, 11.7) | 0.591 | |
| 97.7 (3.3) | 97.7 (2.3) | -0.01 (-1.7, 1.7) | 0.985 | 98 (2) | 98.5 (1.2) | -0.6 (-2, 0.8) | 0.359 | |
| 18.5 (15.2) | 13.7 (10.2) | 5.6 (-3.2, 14.3) | 0.191 | 28.6 (19.1) | 33.3 (40.1) | -5.6 (-61.1, 50) | 0.803 | |
| 5.2 (8.0) | 3.2 (4.5) | 1.7 (-1.7, 5.2) | 0.294 | 5.8 (5.3) | 3.3 (4.7) | 2.8 (1.2, 4.4) | 0.005*** | |
| EQ-5D questionnaire | ||||||||
| 0.436 | 1.000 | |||||||
| No problems | 11 (85) | 12 (92) | 7 (78) | 8 (89) | ||||
| Slight problems | 1 (8) | 1 (8) | 1 (11) | 0 (0) | ||||
| Moderate problems | 1 (8) | 0 (0) | 1 (11) | 0 (0) | ||||
| Severe problems | 0 (0) | 0 (0) | 0 (0) | 1 (11) | ||||
| 0.192 | ||||||||
| No problems | 11 (85) | 11 (85) | 0.674 | 5 (56) | 8 (89) | |||
| Slight problems | 0 (0) | 1 (8) | 4 (44) | 1 (11) | ||||
| Moderate problems | 2 (15) | 1(8) | 0 (0) | 0 (0) | ||||
| 0.100 | ||||||||
| No problems | 13 (100) | 13 (100) | 9 (100) | 9 (100) | ||||
| 0.191 | 1.000 | |||||||
| None | 11 (85) | 7 (54) | 6 (67) | 7 (78) | ||||
| Slight | 1 (8) | 6 (46) | 2 (22) | 2 (22) | ||||
| Moderate | 1 (8) | 0 (0) | 1 (11) | 0 (0) | ||||
| 0.586 | 0.676 | |||||||
| None | 6 (46) | 6 (46) | 6 (67) | 7 (78) | ||||
| Slight | 7 (54) | 7 (54) | 3 (33) | 2 (22) | ||||
| 71.2 (16.4) | 80.5 (14.5) | -8 (-14.4, -1.6) | 0.019* | 76.5 (15.1) | 86.8 (6.4) | -11.1 (-25.1, 2.9) | 0.104 | |
Data are presented as mean (SD) and frequencies with percentages in parentheses. *P < 0.05 taken as statistically significant. ┼Prostate (n = 12), colorectal (n = 9); ǂprostate (n = 13), colorectal (n = 9)
Health-related quality of life at baseline and post-exercise intervention for both surgical-oncology groups combined
| EORTC QLQ-C30 questionnaire┼ | Baseline | Post-intervention | Mean difference (95% CI) | |
|---|---|---|---|---|
| 71.4 (17.2) | 81.5 (14.4) | − 10.6 (− 19.6, − 1.6) | 0.023* | |
| 93.9 (9.2) | 93.6 (9.1) | 0.3 (− 2, 2.6) | 0.792 | |
| 92.4 (16.8) | 90.9 (16.8) | − 1.7 (− 11.1,7.8) | 0.716 | |
| 74.3 (23.2) | 84.8 (11.7) | − 11.3 (− 21.2, − 1.4) | 0.027* | |
| 91.3 (13.2) | 94.9 (9.3) | − 3.8 (− 9.8, 2.2) | 0.204 | |
| 87.0 (23) | 91.3 (12.2) | − 4.5 (− 13.7,4.6) | 0.315 | |
| 97.8 (2.8) | 98.1 (1.9) | − 0.3 (− 1.3,0.8) | 0.614 | |
| 19.2 (17.6) | 20.6 (25.8) | 1.9 (− 13.7, 17.4) | 0.805 | |
| 5.5 (6.7) | 3.3 (4.5) | 2.2 (0.2, 4.1) | 0.030* | |
| EQ-5D questionnaireǂ | ||||
| 0.492 | ||||
| No problems | 18 (82) | 22 (100) | ||
| Slight problems | 2 (9) | 0 (0) | ||
| Moderate problems | 2 (9) | 0 (0) | ||
| Severe problems | 0 (0) | 0 (0) | ||
| 0.213 | ||||
| No problems | 16 (73) | 19 (86) | ||
| Slight problems | 4 (18) | 2 (9) | ||
| Moderate problems | 2 (9) | 1 (5) | ||
| No problems | 22 (100) | 22 (100) | ||
| 0.266 | ||||
| None | 17 (77) | 14 (64) | ||
| Slight | 3 (14) | 8 (36) | ||
| Moderate | 2 (9) | 0 (4) | ||
| 0.492 | ||||
| None | 12 (55) | 13 (59) | ||
| Slight | 10 (45) | 9 (41) | ||
| 73.5 (15.7) | 83.4 (11.7) | − 9.3 (− 15.6, − 3.1) | 0.006* |
Data are presented as mean (SD) and frequencies with percentages in parentheses.*P < 0.05 taken as statistically significant. ┼Overall (n = 21); ǂOverall (n = 22)